Uslu Gonca Hanedan, Çebi Gamze, Çobanoğlu Bengü
Department of Radiation Oncology, Kanuni Research and Education Hospital, Trabzon, Turkey.
Department of Underwater and Hyperbaric Medicine, Kanuni Training and Research Hospital, Trabzon, Turkey.
Contemp Oncol (Pozn). 2018;22(3):202-204. doi: 10.5114/wo.2018.78945. Epub 2018 Sep 30.
One of the standard treatments in laryngeal cancer is radiotherapy (RT). Many short- and long-term complications can occur in the region that has received radiotherapy. Definitive treatment of the emerging complications is still debatable, and treatment is challenging for radiation oncologists and ear nose throat specialists. Recently, hyperbaric oxygen treatment (HBOT) has become a promising alternative for the treatment of these complications. The aim of this report is to discuss the effectiveness of HBOT in the treatment of late-term RT-related potential complications in a patient with laryngeal cancer. We applied HBOT for a 58-year-old male patient with laryngeal cancer for the treatment of laryngeal oedema, and dyspnoea that developed one year after RT. In a decompression chamber at 2.4 atm pressure, the patient was made to breath 100% oxygen with a mask for 90 minutes. At the beginning, HBOT was planned for 30 days; however, it was terminated upon improvement of the symptoms at the 19 session. The symptoms, which developed one year after RT, were relieved completely with HBOT, and the patient is maintaining his life without any complaint under our control. The HBOT can be an alternative treatment for late-term complications developed after radiotherapy. It can be especially used for laryngeal oedema, and dyspnoea related to the field of radiotherapy.
喉癌的标准治疗方法之一是放射治疗(RT)。接受放射治疗的区域可能会出现许多短期和长期并发症。对于新出现并发症的明确治疗仍存在争议,并且对于放射肿瘤学家和耳鼻喉科专家来说,治疗具有挑战性。最近,高压氧治疗(HBOT)已成为治疗这些并发症的一种有前景的替代方法。本报告的目的是讨论HBOT在治疗喉癌患者晚期放疗相关潜在并发症中的有效性。我们对一名58岁的喉癌男性患者应用HBOT治疗放疗一年后出现的喉水肿和呼吸困难。在压力为2.4个大气压的减压舱中,让患者通过面罩呼吸100%的氧气90分钟。开始时,计划进行30天的HBOT治疗;然而,在第19次治疗时症状改善后终止治疗。放疗一年后出现的症状通过HBOT完全缓解,并且患者在我们的观察下维持生活,没有任何不适。HBOT可以作为放疗后晚期并发症的一种替代治疗方法。它尤其可用于治疗喉水肿以及与放疗区域相关的呼吸困难。